COL4A2 and breast carcinoma: Peng et al. (2025), using a decellularized extracellular matrix (dECM) model of breast cancer, demonstrated that COL4A2 overexpression increases ECM stiffness, whereas its silencing reduces ECM elasticity and limits cancer cell invasiveness [22].